Having considered the aforementioned, we wondered how relapse-free survival of patients with luminal primary NMIBC might depend on PD-L1 expression, FGFR3 expression, FGFR3 gene hotspot mutation status, and tumor-associated miRs-145 and -200a assessed in complex. This evidence concerns the gene CD274 and neoplasm.